Helen Heslop, MD is Professor of Medicine and Pediatrics at Baylor College of Medicine, and also directs the Adult Stem Cell Transplant Program at The Methodist Hospital. She is also Associate Director for Clinical Research at the Dan L. Duncan Cancer Center. Dr. Heslop is a physician scientist engaged in translational research focusing on adoptive immunotherapy with gene-modified effector cells, to improve hemopoietic stem cell transplantation and cancer therapy.
Dr. Heslop was a Doris Duke distinguished clinical research scientist and serves as Principal Investigator on several peer-reviewed research programs, including an NCI-funded program project grant (Enhancing T-Cell Therapy of Cancer) a Leukemia and Lymphoma Society Specialized Center of Research (SCOR) award (Immunotherapy of Lymphoma) and a SPORE in lymphoma from the NCI. She is also the principal investigator on an NHLBI-funded training grant in Cell and Gene Therapy. She is the current President of the Foundation for Accreditation of Cell Therapy (FACT) and a past President of the American Society of Blood and Marrow Transplantation. Dr. Heslop is a co-editor of Hematology, 7th Edition.